| Rosetta design with co-evolutionary information retains protein function S Schmitz, M Ertelt, R Merkl, J Meiler PLOS Computational Biology 17 (1), e1008568, 2021 | 13 | 2021 |
| Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy N Meumann, M Cabanes‐Creus, M Ertelt, RG Navarro, J Lucifora, Q Yuan, ... Hepatology, 2022 | 12 | 2022 |
| Combining machine learning with structure-based protein design to predict and engineer post-translational modifications of proteins M Ertelt, VK Mulligan, JB Maguire, S Lyskov, R Moretti, T Schiffner, ... PLOS Computational Biology 20 (3), e1011939, 2024 | 2 | 2024 |
| Combining Rosetta Sequence Design with Protein Language Model Predictions Using Evolutionary Scale Modeling (ESM) as Restraint M Ertelt, J Meiler, CT Schoeder ACS Synthetic Biology 13 (4), 1085-1092, 2024 | 1 | 2024 |
| Modifying immune responses to adeno-associated virus vectors by capsid engineering M Bentler, R Hardet, M Ertelt, D Rudolf, D Kaniowska, A Schneider, ... Molecular Therapy-Methods & Clinical Development 30, 576-592, 2023 | 1 | 2023 |
